MBRX
Moleculin Biotech, Inc.
Company overview
- Market capitalization
- $11.08M
- Employees
- 17
- Latest publication
- 2026-09-29
About Moleculin Biotech, Inc.
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose that cut off the energy supply of tumors. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 63,000USD | 126,000USD | 0USD |
| Research Development | 5,450,000USD | 5,378,000USD | 5,117,000USD | 3,738,000USD | 3,600,000USD | 3,435,000USD | 4,455,000USD | 4,932,000USD |
| Selling General Administrative | 2,103,000USD | 2,488,000USD | 2,407,000USD | 2,147,000USD | 2,091,000USD | 2,477,000USD | 2,157,000USD | 2,172,000USD |
| General And Administrative Expenses | 2,103,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 7,561,000USD | 7,874,000USD | 7,533,000USD | 5,906,000USD | 5,691,000USD | 5,943,000USD | 6,612,000USD | 7,135,000USD |
| Operating Income | -7,561,000USD | -7,874,000USD | -7,533,000USD | -5,906,000USD | -5,720,000USD | -5,943,000USD | -6,643,000USD | -7,135,000USD |
| Total Other Income Expense Net | -74,000USD | -4,971,000USD | 23,085,000USD | -19,493,000USD | -1,920,000USD | -493,000USD | 4,761,000USD | -3,457,000USD |
| Income Before Tax | -7,635,000USD | -12,845,000USD | 15,552,000USD | -25,399,000USD | -7,640,000USD | -6,436,000USD | -1,882,000USD | -10,592,000USD |
| Income Tax Expense | 0USD | — | — | — | — | — | — | — |
| Net Income | -7,635,000USD | -12,845,000USD | 15,552,000USD | -25,399,000USD | -7,640,000USD | -6,436,000USD | -1,882,000USD | -10,592,000USD |
| Net Income Applicable To Common Shares | -7,964,000USD | — | — | — | — | — | — | — |
| Cost Of Revenue | — | 8,000USD | 9,000USD | 21,000USD | 29,000USD | 31,000USD | 31,000USD | 31,000USD |
| Gross Profit | — | -8,000USD | -9,000USD | -21,000USD | -29,000USD | -31,000USD | -31,000USD | -31,000USD |
| Interest Income | — | 34,000USD | 9,000USD | 39,000USD | 26,000USD | 30,000USD | 47,000USD | 102,000USD |
| Net Interest Income | — | 34,000USD | 9,000USD | 39,000USD | 26,000USD | 30,000USD | 47,000USD | 102,000USD |
| Net Income From Continuing Ops | — | -12,845,000USD | 15,552,000USD | -25,399,000USD | -7,640,000USD | -6,436,000USD | -1,882,000USD | -10,592,000USD |
| Ebit | — | -7,874,000USD | -7,533,000USD | -5,906,000USD | -7,640,000USD | -5,943,000USD | -1,882,000USD | -7,135,000USD |
| Ebitda | — | -7,866,000USD | -7,524,000USD | -5,884,000USD | -7,611,000USD | -5,912,000USD | -1,851,000USD | -7,103,000USD |
| Depreciation And Amortization | — | 8,000USD | 9,000USD | 22,000USD | 29,000USD | 31,000USD | 31,000USD | 32,000USD |
| Reconciled Depreciation | — | 8,000USD | 9,000USD | 22,000USD | 28,000USD | 31,000USD | 31,000USD | 32,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 90,000USD | 126,000USD | 127,000USD | 222,000USD | 260,000USD | 285,000USD | 185,000USD | 68,000USD |
| Gross Profit | -90,000USD | -126,000USD | -127,000USD | -222,000USD | -260,000USD | -285,000USD | -185,000USD | -68,000USD |
| Research Development | 15,891,000USD | 17,729,000USD | 19,487,000USD | 18,968,000USD | 14,418,000USD | 12,757,000USD | 11,013,000USD | 9,728,000USD |
| Selling General Administrative | 9,122,000USD | 8,786,000USD | 10,017,000USD | 11,542,000USD | 8,386,000USD | 6,785,000USD | 6,312,000USD | 5,297,000USD |
| Total Operating Expenses | 25,103,000USD | 26,641,000USD | 29,631,000USD | 30,640,000USD | 22,968,000USD | 19,742,000USD | 17,339,000USD | 15,025,000USD |
| Operating Income | -25,103,000USD | -26,641,000USD | -29,631,000USD | -30,640,000USD | -22,968,000USD | -19,742,000USD | -17,524,000USD | -15,025,000USD |
| Interest Income | 105,000USD | 550,000USD | 1,232,000USD | 240,000USD | 306,000USD | 13,000USD | 4,075,000USD | 3,189,000USD |
| Net Interest Income | 105,000USD | 550,000USD | 1,232,000USD | 240,000USD | 306,000USD | 13,000USD | 13,000USD | 4,000USD |
| Income Before Tax | -33,560,000USD | -21,763,000USD | -29,769,000USD | -29,025,000USD | -15,894,000USD | -17,355,000USD | -13,434,000USD | -11,876,000USD |
| Net Income | -33,560,000USD | -21,763,000USD | -29,769,000USD | -29,025,000USD | -15,894,000USD | -17,355,000USD | -13,205,000USD | -11,876,000USD |
| Net Income From Continuing Ops | -33,560,000USD | -21,763,000USD | -26,270,000USD | -29,025,000USD | -15,894,000USD | -17,355,000USD | -13,205,000USD | -11,876,000USD |
| Ebit | -25,103,000USD | -26,641,000USD | -29,631,000USD | -30,640,000USD | -22,968,000USD | -19,742,000USD | -13,434,000USD | -15,025,000USD |
| Ebitda | -25,013,000USD | -26,515,000USD | -29,504,000USD | -30,510,000USD | -22,804,000USD | -19,542,000USD | -13,249,000USD | -14,957,000USD |
| Depreciation And Amortization | 90,000USD | 126,000USD | 127,000USD | 130,000USD | 164,000USD | 200,000USD | 185,000USD | 68,000USD |
| Reconciled Depreciation | 90,000USD | 126,000USD | 124,000USD | 130,000USD | 164,000USD | 200,000USD | 199,000USD | 68,000USD |
| Total Other Income Expense Net | -8,457,000USD | 4,878,000USD | -138,000USD | 1,615,000USD | 7,074,000USD | 2,387,000USD | 4,090,000USD | 3,149,000USD |
| Interest Expense | — | — | — | 1,615,000USD | 7,074,000USD | 13,000USD | 8,152,000USD | 0USD |
| Income Tax Expense | — | — | — | -1,615,000USD | -7,034,000USD | -2,359,000USD | -229,000USD | 3,145,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | -15,894,000USD | -17,355,000USD | -13,205,000USD | -11,876,000USD |
| Tax Provision | — | — | — | — | — | 0USD | -229,000USD | — |
| Non Operating Income Net Other | — | — | — | — | — | 2,374,000USD | 4,077,000USD | 3,145,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 21,087,000USD | 23,363,000USD | 22,126,000USD | 20,353,000USD | 21,593,000USD | 21,013,000USD | 16,925,000USD | 23,394,000USD |
| Cash And Equivalents | 7,262,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 8,723,000USD | 10,961,000USD | 9,686,000USD | 7,885,000USD | 9,076,000USD | 9,340,000USD | 5,194,000USD | 11,606,000USD |
| Other Current Assets | 1,461,000USD | 644,000USD | 801,000USD | 1,176,000USD | 1,514,000USD | 1,618,000USD | 916,000USD | 2,201,000USD |
| Other Non Current Assets | 900,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 9,500,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 9,313,000USD | 7,962,000USD | 6,854,000USD | 5,682,000USD | 7,913,000USD | 6,896,000USD | 5,359,000USD | 5,593,000USD |
| Other Current Liabilities | 4,976,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 11,587,000USD | 15,183,000USD | 15,006,000USD | -26,920,000USD | -7,165,000USD | 42,000USD | 5,979,000USD | 7,479,000USD |
| Total Equity Including Noncontrolling Interest | 11,587,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 316,000USD | 284,000USD | 314,000USD | 420,000USD | 469,000USD | 525,000USD | 583,000USD | 640,000USD |
| Accounts Payable | 4,337,000USD | 4,574,000USD | 3,508,000USD | 2,116,000USD | 3,721,000USD | 2,706,000USD | 2,030,000USD | 2,550,000USD |
| Short Term Debt | 145,000USD | — | 137,000USD | 132,000USD | 128,000USD | 124,000USD | 120,000USD | 116,000USD |
| Common Stock | 7,000USD | 5,000USD | 3,000USD | 49,000USD | 30,000USD | 14,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -226,484,000USD | -218,849,000USD | -206,004,000USD | -221,556,000USD | -167,443,000USD | -159,803,000USD | -153,367,000USD | -151,485,000USD |
| Accumulated Other Comprehensive Income | -64,000USD | -52,000USD | 10,000USD | -44,000USD | -38,000USD | -38,000USD | -41,000USD | 4,000USD |
| Intangible Assets | — | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD |
| Total Liab | — | 8,180,000USD | 7,120,000USD | 47,273,000USD | 28,758,000USD | 20,971,000USD | 10,946,000USD | 15,915,000USD |
| Other Current Liab | — | 3,388,000USD | 3,209,000USD | 3,434,000USD | 4,064,000USD | 4,066,000USD | 3,209,000USD | 2,927,000USD |
| Capital Stock | — | 5,000USD | 3,000USD | 49,000USD | 30,000USD | 14,000USD | 3,000USD | 3,000USD |
| Cash | — | 10,317,000USD | 8,878,000USD | 6,703,000USD | 7,557,000USD | 7,716,000USD | 4,278,000USD | 9,405,000USD |
| Cash And Short Term Investments | — | 10,317,000USD | 8,878,000USD | 6,703,000USD | 7,557,000USD | 7,716,000USD | 4,278,000USD | 9,405,000USD |
| Net Debt | — | -10,132,000USD | -8,519,000USD | -6,313,000USD | -7,137,000USD | -7,266,000USD | -3,800,000USD | -8,899,000USD |
| Short Long Term Debt Total | — | 185,000USD | 359,000USD | 390,000USD | 420,000USD | 450,000USD | 478,000USD | 506,000USD |
| Property Plant Equipment Gross | — | 354,000USD | 392,000USD | 420,000USD | 469,000USD | 525,000USD | 1,605,000USD | 640,000USD |
| Common Stock Shares Outstanding | — | 41,244,820shares | 11,845,690shares | 1,492,178shares | 621,056shares | 3,737shares | 135,156shares | 148,571shares |
| Non Current Assets Total | — | 12,402,000USD | 12,440,000USD | 12,468,000USD | 12,517,000USD | 11,673,000USD | 11,731,000USD | 11,788,000USD |
| Non Current Liabilities Total | — | 218,000USD | 266,000USD | 41,591,000USD | 20,845,000USD | 14,075,000USD | 5,587,000USD | 10,322,000USD |
| Non Currrent Assets Other | — | 970,000USD | 978,000USD | 900,000USD | 900,000USD | 127,000USD | — | 190,000USD |
| Net Working Capital | — | 2,999,000USD | 2,832,000USD | 2,203,000USD | 1,163,000USD | 2,444,000USD | -165,000USD | 6,013,000USD |
| Unclassified Equity | — | 234,074,000USD | 220,994,000USD | 194,582,000USD | 160,256,000USD | 159,855,000USD | 159,381,000USD | 158,954,000USD |
| Net Receivables | — | — | 7,000USD | 6,000USD | 5,000USD | 6,000USD | 20,000USD | — |
| Unclassified Non Current Liabilities | — | — | — | 41,591,000USD | 20,845,000USD | 14,075,000USD | 5,587,000USD | 10,322,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 22,126,000USD | 16,925,000USD | 38,217,000USD | 57,422,000USD | 84,090,000USD | 29,160,000USD | 25,235,000USD | 19,585,000USD |
| Intangible Assets | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD | 11,148,000USD |
| Other Current Assets | 801,000USD | 916,000USD | 2,723,000USD | 2,451,000USD | 1,549,000USD | 2,024,000USD | 2,738,000USD | 955,000USD |
| Total Liab | 7,120,000USD | 10,946,000USD | 12,144,000USD | 5,231,000USD | 5,097,000USD | 11,271,000USD | 9,664,000USD | 5,313,000USD |
| Total Stockholder Equity | 15,006,000USD | 5,979,000USD | 26,073,000USD | 52,191,000USD | 78,993,000USD | 17,889,000USD | 15,571,000USD | 14,272,000USD |
| Other Current Liab | 3,209,000USD | 3,209,000USD | 4,217,000USD | 2,608,000USD | 2,162,000USD | 1,673,000USD | 1,314,000USD | 2,632,000USD |
| Common Stock | 3,000USD | 3,000USD | 33,000USD | 29,000USD | 29,000USD | 69,000USD | 46,000USD | 29,000USD |
| Capital Stock | 3,000USD | 3,000USD | 33,000USD | 29,000USD | 29,000USD | 69,000USD | 46,000USD | 29,000USD |
| Retained Earnings | -206,004,000USD | -153,367,000USD | -131,604,000USD | -101,835,000USD | -72,810,000USD | -56,916,000USD | -39,561,000USD | -26,356,000USD |
| Cash | 8,878,000USD | 4,278,000USD | 23,550,000USD | 43,145,000USD | 70,903,000USD | 15,173,000USD | 10,735,000USD | 7,134,000USD |
| Cash And Short Term Investments | 8,878,000USD | 4,278,000USD | 23,550,000USD | 43,145,000USD | 70,903,000USD | 15,173,000USD | 10,735,000USD | 7,134,000USD |
| Total Current Assets | 9,686,000USD | 5,194,000USD | 26,273,000USD | 45,596,000USD | 72,497,000USD | 17,198,000USD | 13,484,000USD | 7,974,000USD |
| Total Current Liabilities | 6,854,000USD | 5,359,000USD | 6,815,000USD | 4,819,000USD | 3,622,000USD | 2,920,000USD | 3,570,000USD | 3,878,000USD |
| Net Debt | -8,519,000USD | -3,800,000USD | -22,976,000USD | -42,694,000USD | -70,744,000USD | -14,896,000USD | -10,356,000USD | -7,134,000USD |
| Short Term Debt | 137,000USD | 120,000USD | 100,000USD | 116,000USD | 96,000USD | 118,000USD | 103,000USD | 180,000USD |
| Short Long Term Debt Total | 359,000USD | 478,000USD | 574,000USD | 451,000USD | 159,000USD | 277,000USD | 379,000USD | — |
| Net Receivables | 7,000USD | 20,000USD | 99,000USD | 22,000USD | 45,000USD | 1,000USD | 11,000USD | 56,000USD |
| Accounts Payable | 3,508,000USD | 2,030,000USD | 2,498,000USD | 2,095,000USD | 1,364,000USD | 1,129,000USD | 2,153,000USD | 1,246,000USD |
| Property Plant Equipment Net | 314,000USD | 583,000USD | 796,000USD | 678,000USD | 445,000USD | 685,000USD | 603,000USD | 463,000USD |
| Property Plant Equipment Gross | 392,000USD | 1,605,000USD | 1,692,000USD | 678,000USD | 1,083,000USD | 685,000USD | 603,000USD | 463,000USD |
| Accumulated Other Comprehensive Income | 10,000USD | -41,000USD | -9,000USD | 12,000USD | 41,000USD | 65,000USD | 31,000USD | 35,000USD |
| Common Stock Shares Outstanding | 11,845,690shares | 137,720shares | 79,024shares | 76,278shares | 71,669shares | 26,255shares | 18,098shares | 11,513shares |
| Non Current Assets Total | 12,440,000USD | 11,731,000USD | 11,944,000USD | 11,826,000USD | 11,593,000USD | 11,962,000USD | 11,751,000USD | 11,611,000USD |
| Non Current Liabilities Total | 266,000USD | 5,587,000USD | 5,329,000USD | 412,000USD | 1,475,000USD | 8,351,000USD | 6,093,999USD | 1,435,000USD |
| Non Currrent Assets Other | 978,000USD | 159,000USD | -1USD | 275,000USD | 338,000USD | -11,833USD | 11,148,000USD | 11,148,000USD |
| Net Working Capital | 2,832,000USD | -165,000USD | 19,458,000USD | 40,777,000USD | 68,875,000USD | 14,278,000USD | 9,914,000USD | 4,096,000USD |
| Unclassified Equity | 220,994,000USD | 159,381,000USD | 157,620,000USD | 153,956,000USD | 151,704,000USD | 74,602,000USD | 55,009,000USD | 40,535,000USD |
| Unclassified Non Current Liabilities | — | 5,587,000USD | 5,329,000USD | — | — | — | -5,818,001USD | -1,435,000USD |
| Other Assets | — | — | 1USD | — | — | 685,000USD | — | — |
| Inventory | — | — | 1USD | -22,000USD | -45,000USD | 1,860,000USD | 2,209,000USD | — |
| Other Liab | — | — | — | — | 1,412,000USD | 8,192,000USD | 5,818,000USD | 1,435,000USD |
| Net Tangible Assets | — | — | — | — | 67,845,000USD | 6,612,000USD | 4,423,000USD | 3,124,000USD |
| Unclassified Current Assets | — | — | — | — | — | -1,860,000USD | -2,209,000USD | — |
| Deferred Long Term Liab | — | — | — | — | — | — | 5,818,000USD | 1,435,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | 1,150,000USD | — |
| Non Current Liabilities Other | — | — | — | — | — | — | 276,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | — | — | -11,148,000USD | -11,148,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | -1,150,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 16,000USD |
| Stock Based Compensation | 816,000USD |
| Change To Liabilities | 2,459,000USD |
| Change In Working Capital | 829,000USD |
| Operating Cash Flow | -12,768,000USD |
| Investing Cash Flow | 0USD |
| Financing Cash Flow | 11,225,000USD |
| Effect Of Forex Changes On Cash | -73,000USD |
| Change In Cash | -1,616,000USD |
| End Cash Flow | 7,262,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -12,845,000USD | 15,552,000USD | -25,399,000USD | -7,640,000USD | -6,436,000USD | -1,882,000USD | -10,592,000USD | -4,319,000USD |
| Depreciation | 8,000USD | 9,000USD | 21,000USD | 28,000USD | 31,000USD | 31,000USD | 32,000USD | 31,000USD |
| Stock Based Compensation | 380,000USD | 459,000USD | 303,000USD | 417,000USD | 485,000USD | 427,000USD | 353,000USD | 453,000USD |
| Other Non Cash Items | 5,215,000USD | -23,265,000USD | 19,850,000USD | 1,948,000USD | 650,000USD | -4,705,000USD | 3,566,000USD | -1,696,000USD |
| Change In Working Capital | 1,131,000USD | 1,879,000USD | -1,695,000USD | -335,000USD | 706,000USD | 1,046,000USD | 528,000USD | -418,000USD |
| Total Cash From Operating Activities | -6,111,000USD | -5,366,000USD | -7,223,000USD | -5,582,000USD | -4,564,000USD | -5,083,000USD | -6,113,000USD | -5,949,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | -13,000USD |
| Free Cash Flow | -6,111,000USD | -5,366,000USD | -7,223,000USD | -5,582,000USD | -4,564,000USD | -5,083,000USD | -6,113,000USD | -5,962,000USD |
| Total Cash From Financing Activities | 7,612,000USD | 7,487,000USD | 6,375,000USD | 5,423,000USD | 7,999,000USD | 1,000USD | 4,659,000USD | -25,000USD |
| Dividends Paid | -1,765,000USD | -104,000USD | — | — | — | — | — | — |
| Issuance Of Capital Stock | 7,612,000USD | 7,089,000USD | 5,264,000USD | 5,417,000USD | 7,995,000USD | 0USD | 4,660,000USD | 0USD |
| Change In Cash | 1,439,000USD | 2,175,000USD | -854,000USD | -159,000USD | 3,438,000USD | -5,127,000USD | -1,440,000USD | -5,979,000USD |
| Begin Period Cash Flow | 8,878,000USD | 6,703,000USD | 7,557,000USD | 7,716,000USD | 4,278,000USD | 9,405,000USD | 10,845,000USD | 16,824,000USD |
| End Period Cash Flow | 10,317,000USD | 8,878,000USD | 6,703,000USD | 7,557,000USD | 7,716,000USD | 4,278,000USD | 9,405,000USD | 10,845,000USD |
| Other Cashflows From Financing Activities | 1,765,000USD | -8,000USD | 6,375,000USD | 6,000USD | 4,000USD | 4,661,000USD | -1,000USD | -24,975USD |
| Investments | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | -13,000USD |
| Unclassified Financing Cash Flow | — | — | -5,264,000USD | — | 7,994,975USD | -4,660,000USD | 4,660,001USD | — |
| Sale Purchase Of Stock | — | — | — | — | 25USD | — | -1USD | -25USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | — | — | -13,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -33,560,000USD | -21,763,000USD | -29,769,000USD | -29,025,000USD | -15,894,000USD | -17,355,000USD | -13,205,000USD | -11,876,000USD |
| Depreciation | 90,000USD | 126,000USD | 127,000USD | 130,000USD | 164,000USD | 200,000USD | 199,000USD | 68,000USD |
| Stock Based Compensation | 1,664,000USD | 1,726,000USD | 1,984,000USD | 2,275,000USD | 2,373,000USD | 1,680,000USD | 1,537,000USD | 1,140,000USD |
| Other Non Cash Items | 8,516,000USD | -4,182,000USD | 1,935,000USD | -1,243,000USD | 96,000USD | 85,000USD | -3,587,000USD | -3,145,000USD |
| Change In Working Capital | 555,000USD | 231,000USD | 1,622,000USD | 224,000USD | 1,038,000USD | -41,000USD | -2,142,000USD | 1,610,000USD |
| Total Cash From Operating Activities | -22,735,000USD | -23,862,000USD | -24,101,000USD | -27,639,000USD | -18,951,000USD | -17,771,000USD | -17,198,000USD | -12,203,000USD |
| Capital Expenditures | 0USD | -13,000USD | -124,000USD | -67,000USD | -19,000USD | -376,000USD | -52,000USD | -417,000USD |
| Free Cash Flow | -22,735,000USD | -23,875,000USD | -24,225,000USD | -27,706,000USD | -18,970,000USD | -18,147,000USD | -17,250,000USD | -12,620,000USD |
| Total Cash From Financing Activities | 27,284,000USD | 4,635,000USD | 4,651,000USD | -23,000USD | 74,724,000USD | 22,549,000USD | 20,854,000USD | 12,045,000USD |
| Dividends Paid | -104,000USD | — | — | — | — | — | — | — |
| Issuance Of Capital Stock | 25,765,000USD | 4,660,000USD | 211,000USD | -1,000USD | 74,684,000USD | 22,561,000USD | 19,292,000USD | 12,025,000USD |
| Change In Cash | 4,600,000USD | -19,272,000USD | -19,595,000USD | -27,758,000USD | 55,730,000USD | 4,438,000USD | 3,601,000USD | -580,000USD |
| Begin Period Cash Flow | 4,278,000USD | 23,550,000USD | 43,145,000USD | 70,903,000USD | 15,173,000USD | 10,735,000USD | 7,134,000USD | 7,714,000USD |
| End Period Cash Flow | 8,878,000USD | 4,278,000USD | 23,550,000USD | 43,145,000USD | 70,903,000USD | 15,173,000USD | 10,735,000USD | 7,134,000USD |
| Other Cashflows From Financing Activities | -8,000USD | -25,000USD | 485,000USD | -23,000USD | 40,000USD | -12,000USD | 1,562,000USD | 20,000USD |
| Unclassified Financing Cash Flow | 1,631,000USD | — | 4,166,025USD | — | 74,684,023USD | 22,561,017USD | -1,562,000USD | — |
| Investments | — | -13,000USD | -43,000USD | -67,000USD | -19,000USD | -374,000USD | -51,000USD | -417,000USD |
| Total Cashflows From Investing Activities | — | -13,000USD | -124,000USD | -67,000USD | -19,000USD | -374,000USD | -51,000USD | -417,000USD |
| Sale Purchase Of Stock | — | — | -25USD | -23,000USD | -23USD | -17USD | 20,854,000USD | 12,045,000USD |
| Change To Liabilities | — | — | — | — | 235,000USD | -1,024,000USD | -233,000USD | 1,862,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -6,728,000USD | -2,340,000USD | — | — |
| Change To Account Receivables | — | — | — | — | — | 129,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 4,404,000USD | 3,605,000USD | -580,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | 2USD | 1,000USD | — |
| Exchange Rate Changes | — | — | — | — | — | — | — | -5,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.